Get the Stockscreener App
54.78
1.18%
-0.43
Protagonist Therapeutics Inc Stock (PTGX) Forecast
The Protagonist Therapeutics Inc (PTGX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $35.95, representing a -34.38% decrease from the current price of $54.78. The highest analyst price target is $37.93, and the lowest is $33.96.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PTGX Price Target
Average 44.20
(-19.32% Downside)
Is Protagonist Therapeutics Inc (PTGX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.60 | Neutral |
| STOCH(9,6) | 66.21 | Neutral |
| STOCHRSI(14) | 19.70 | Buy |
| MACD(12,26) | 2.5835 | Buy |
| ADX(14) | 42.15 | Buy |
| William %R | -29.64 | Neutral |
| CCI(14) | 15.16 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
55.24
Sell
|
54.28
Sell
|
| MA20 |
51.49
Buy
|
52.23
Buy
|
| MA50 |
47.31
Buy
|
48.95
Buy
|
| MA100 |
45.44
Buy
|
46.53
Buy
|
| MA200 |
44.19
Buy
|
43.03
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, PTGX could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on PTGX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.6 indicates that PTGX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 66.21 indicates that PTGX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 19.7 indicates that PTGX is oversold. This suggests that PTGX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 42.15 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 15.16 indicates that PTGX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PTGX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Protagonist Therapeutics Inc financial reports and earnings history, Protagonist Therapeutics Inc (PTGX) stock could reach $42.89 by 2030, $117.35 by 2040 and $159.24 by 2050. See the projected annual prices until 2050 of the Protagonist Therapeutics Inc stock below:
- Protagonist Therapeutics Inc (PTGX) is expected to reach an average price of $83.87 in 2035, with a high prediction of $84.23 and a low estimate of $79.85. This indicates an $53.11% rise from the last recorded price of $54.78.
- Protagonist Therapeutics Inc (PTGX) stock is projected to chart a bullish course in 2040, with an average price target of $115.47, representing an $110.79% surge from its current level. The forecast ranges from a conservative $109.89 to a sky-high $117.35.
- Our analysts predict Protagonist Therapeutics Inc (PTGX) to jump 124.46% by 2045, soaring from $121.49 to an average price of $122.96, potentially reaching $123.73. While $121.49 is the low estimate, the potential upside is significant.
- Protagonist Therapeutics Inc (PTGX) stock is expected to climb by 2050, reaching an average of $159.01, a $190.28% jump from its current level. However, a wide range of estimates exists, with high and low targets of $159.24 and $154.42, respectively, highlighting the market's uncertainty.
Protagonist Therapeutics Inc Stock (PTGX) Year by Year Forecast
Protagonist Therapeutics Inc Stock (PTGX) Price Forecast for 2025
Protagonist Therapeutics Inc Stock (PTGX) is expected to reach an average price of $33.55 in 2025, with a high prediction of $43.57 and a low estimate of $23.53. This indicates an -38.76% fall from the last recorded price of $54.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $36.72 | $33.96 | $37.93 | -32.97% |
| August, 2025 | $35.84 | $35.69 | $39.01 | -34.57% |
| September, 2025 | $37.79 | $34.52 | $38.11 | -31.02% |
| October, 2025 | $40.70 | $34.06 | $42.79 | -25.71% |
| November, 2025 | $40.00 | $39.42 | $43.57 | -26.97% |
| December, 2025 | $39.75 | $38.24 | $43.39 | -27.43% |
Protagonist Therapeutics Inc Stock (PTGX) Price Forecast for 2026
The predicted value for Protagonist Therapeutics Inc (PTGX) in 2026 is set at an average of $55.95. Estimates vary from a peak of $74.75 to a trough of $37.15, indicating an +2.14% surge from the present price of $54.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $44.93 | $39.62 | $46.04 | -17.98% |
| February, 2026 | $42.48 | $40.84 | $46.12 | -22.46% |
| March, 2026 | $46.01 | $40.39 | $47.08 | -16.02% |
| April, 2026 | $47.61 | $41.96 | $49.22 | -13.08% |
| May, 2026 | $53.41 | $44.56 | $53.86 | -2.50% |
| June, 2026 | $49.12 | $46.93 | $54.43 | -10.33% |
| July, 2026 | $53.36 | $46.75 | $54.45 | -2.59% |
| August, 2026 | $62.81 | $52.26 | $63.63 | +14.65% |
| September, 2026 | $69.70 | $60.92 | $70.79 | +27.24% |
| October, 2026 | $71.91 | $66.86 | $73.74 | +31.28% |
| November, 2026 | $72.57 | $69.77 | $74.35 | +32.48% |
| December, 2026 | $42.14 | $37.15 | $74.75 | -23.08% |
Protagonist Therapeutics Inc Stock (PTGX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Protagonist Therapeutics Inc (PTGX) is $48.70, with a high forecast of $63.09 and a low forecast of $34.32. This indicates an -11.09% decrease from the last price of $54.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $55.65 | $41.75 | $61.73 | +1.58% |
| February, 2027 | $60.01 | $54.78 | $63.09 | +9.54% |
| March, 2027 | $55.68 | $53.52 | $60.82 | +1.65% |
| April, 2027 | $61.56 | $54.17 | $62.58 | +12.38% |
| May, 2027 | $54.12 | $51.70 | $61.83 | -1.21% |
| June, 2027 | $50.54 | $48.65 | $55.19 | -7.74% |
| July, 2027 | $50.19 | $49.23 | $53.78 | -8.39% |
| August, 2027 | $45.69 | $45.45 | $52.47 | -16.59% |
| September, 2027 | $36.03 | $34.52 | $45.92 | -34.22% |
| October, 2027 | $35.27 | $34.32 | $36.85 | -35.62% |
| November, 2027 | $37.31 | $35.31 | $37.36 | -31.89% |
| December, 2027 | $39.44 | $36.57 | $40.01 | -28.01% |
Protagonist Therapeutics Inc Stock (PTGX) Price Forecast for 2028
In 2028, Protagonist Therapeutics Inc (PTGX) is projected to reach an average price of $48.87, with a high projection of $61.61 and a low estimate of $36.13. This indicates an -10.78% fall from the last price of $54.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $37.16 | $36.74 | $39.63 | -32.16% |
| February, 2028 | $37.02 | $36.13 | $37.58 | -32.42% |
| March, 2028 | $37.04 | $36.60 | $37.74 | -32.38% |
| April, 2028 | $36.82 | $36.61 | $37.78 | -32.79% |
| May, 2028 | $39.66 | $36.52 | $39.70 | -27.61% |
| June, 2028 | $41.50 | $39.62 | $42.88 | -24.23% |
| July, 2028 | $47.33 | $41.12 | $48.09 | -13.59% |
| August, 2028 | $55.47 | $45.48 | $56.02 | +1.26% |
| September, 2028 | $49.22 | $48.39 | $56.23 | -10.15% |
| October, 2028 | $55.84 | $48.67 | $57.11 | +1.93% |
| November, 2028 | $59.57 | $55.22 | $59.63 | +8.75% |
| December, 2028 | $59.27 | $58.33 | $61.61 | +8.20% |
Protagonist Therapeutics Inc Stock (PTGX) Price Forecast for 2029
The 2029 price forecast for Protagonist Therapeutics Inc Stock (PTGX) is $53.27 on average, with a high prediction of $67.84 and a low estimate of $38.69. This represents an -2.76% decrease from the previous price of $54.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $51.40 | $48.37 | $58.53 | -6.17% |
| February, 2029 | $52.20 | $49.96 | $52.86 | -4.71% |
| March, 2029 | $50.46 | $49.95 | $52.81 | -7.89% |
| April, 2029 | $48.28 | $47.99 | $50.86 | -11.87% |
| May, 2029 | $48.67 | $46.69 | $50.37 | -11.15% |
| June, 2029 | $52.02 | $48.30 | $52.21 | -5.04% |
| July, 2029 | $56.67 | $51.60 | $57.62 | +3.45% |
| August, 2029 | $59.10 | $55.24 | $61.98 | +7.88% |
| September, 2029 | $62.85 | $59.23 | $63.81 | +14.72% |
| October, 2029 | $62.74 | $62.54 | $67.84 | +14.54% |
| November, 2029 | $60.60 | $59.78 | $64.13 | +10.63% |
| December, 2029 | $40.38 | $38.69 | $62.84 | -26.29% |
Protagonist Therapeutics Inc Stock (PTGX) Price Forecast for 2030
Protagonist Therapeutics Inc Stock (PTGX) is expected to reach an average price of $43.82 in 2030, with a high forecast of $48.94 and a low forecast of $38.70. This signifies an -20.00% decrease from the last price of $54.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $42.03 | $39.70 | $42.89 | -23.28% |
| February, 2030 | $44.18 | $41.65 | $44.86 | -19.35% |
| March, 2030 | $41.73 | $41.58 | $44.51 | -23.83% |
| April, 2030 | $45.03 | $39.92 | $45.43 | -17.80% |
| May, 2030 | $44.71 | $44.55 | $48.94 | -18.38% |
| June, 2030 | $45.36 | $43.79 | $45.68 | -17.19% |
| July, 2030 | $43.45 | $43.29 | $47.31 | -20.68% |
| August, 2030 | $41.90 | $38.70 | $43.70 | -23.51% |
| September, 2030 | $42.02 | $41.45 | $42.62 | -23.30% |
| October, 2030 | $44.11 | $41.84 | $44.43 | -19.48% |
| November, 2030 | $43.90 | $42.89 | $45.42 | -19.87% |
| December, 2030 | $43.03 | $41.76 | $44.07 | -21.44% |
1.59%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):